ETFs Investors Skittish About Near-Term Outlook of Biotechs

The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotech exchange traded fund by assets, lost nearly a quarter of its value in the first quarter. Some other biotech ETFs turned in worse performances and that has investors skittish about the near-term outlook for the once red-hot...